It has been just over a month since the American Heart Association Scientific Session 2021 concluded and I am elated to be a part of the Early Career Blogger program with a sponsored free access to the scientific sessions which also included the media pass! My first thought after glancing at the schedule was, there … Read more
The AHA ReSS council had a fascinating 2021 meeting, including trials making us reassess the optimal temperature for patients following cardiac arrest (TTM2) and those investigating the potential new application of existing meds repurposed to cardiac arrest (e.g. Tocilizumab [IL-6 inhibitor] to reduce cytokine storm post-arrest, LPC-DHA to improve mitochondrial function). What really put these … Read more
Mental health was a big topic of conversation at AHA21, a fitting topic when pandemic related stress, clinician burn out, and depression seem to be at an all-time high. As a graduate student myself, I was interested in attending sessions that touched on depression, wellness, and work-life balance topics. A Health and Tech panel session … Read more
It is safe to say that AHA Scientific Sessions 2021, conducted virtually from November 13th to 15th was a big hit. The ease and flexibility of attending the Sessions from the comfort of my couch made me forget my initial concerns of missing out on the in-person experience. It will be interesting to see how … Read more
Atherosclerotic cardiovascular disease (CVD) prevention has been traditionally divided into primary or pre-event prevention and secondary or re-event prevention. The AHA 2021 joint session with the American Society of Preventive Cardiology entitled “Blurred Lines-Overlap in High-Risk Primary Prevention vs Secondary Prevention” challenged this traditional concept. The session tackled the case of a high-risk patient where … Read more
Cardiovascular diseases (CVD) are the leading cause of death in Western countries and accounts for 17.3 million deaths/year globally1. In the United States, one in every three deaths are caused by CVD, and more than 130 million adults are projected to express CVD by 2035 clinically1. The unhealthy diet and physical inactivity, obesity, stress, smoking, … Read more
2021 Guideline for the Evaluation and Diagnosis of Chest Pain was released in October 2021 and discussed in multiple sessions during AHA21. It was a collaboration between cardiologists, interventional cardiologists, cardiac intensivists, epidemiologists, and emergency medicine specialists. The team has focused on a symptom rather than a disease, making this approach unique. In the U.S, … Read more
As you may know, health equity was a major focus of the AHA 2021 Scientific Sessions, with numerous sessions that focused on cardiovascular health disparities, equity in treatment of cardiovascular disease and plenty of original health equity research. Here is a run-down of some great presentations about important topics in cardiovascular health equity from #AHA21, … Read more
I was delighted to be selected as one of the American Heart Association (AHA) early career fellows in training bloggers for the year 2021-2022 during my first-year cardiology fellow. During 2019, the AHA conference was in Philadelphia and in-person. However, with the COVID-19 pandemic surge, we have learned how to attend virtual to hybrid conferences. … Read more
It has been a month after the American Heart Association (AHA) Scientific Sessions 2021. Not only was this year my first time attending the conference, but it was also my first time ever covering a scientific meeting as an early career blogger. As a participant in the AHA Early Career and FIT Blogging program, the … Read more